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Summary: Heikkila & Cabbat (Anal. Biochem. 75, 356-362
(1976)) have proposed the autoxidation of the 6-hydroxydop-
amine s a method to test Superoxide dismutase activity in
biological samples. This method has several advantages but in
some instances leads to incorrect determinations. We present
here a necessary modification of the method to avoid bias.
Introduction
Superoxide dismutase (EC 1.15.1.1) is an ubiquitous enzyme
which catalyses the dismutatibn of the Superoxide radical (O^)
to hydrogen peroxide (H2O2) and O2. Determination of this
activity has become a cufrent practice since the discovery of
the role of free radicals in a l rge number of pathological
conditions such s inflammation, radiation injury, ischemia,
aging, neoplastic processes, and syndr mes due to chromo-
somal abnorm lities.
In the current method for the determination of Superoxide
dismutase, O^ (generated enzymatically or nonenzymatically)
is allowed to oxidize an indicator, and this reaction is monitored
spectrophotometrically from the resulting absorbancy change.
Superoxide dismutase destroys O^ and thereby decreases the
initial rate of the absorbancy change of the indicator. This
reduction in rate is a measure of Superoxide dismutase activity.
Heikkila & Cabbal have proposed autoxidation of 6rhydroxy-
dopamine s a convenient and sensitive method for testing
Superoxide dismutase activity in biological extracts. The advan-
tages of this method are:
a) the pH (7.4) used in the assay makes it .possible to rneasure
both Mn Superoxide dismutase, inactive at pH higher than
9, and CuZn Superoxide dismutase;
b) the large absorbance increase of oxidized 6-hydroxydop-
amine, an advantage particularly relevant in tissues where
the Superoxide dismutase content is relatively low;
c) the assay is rapid;
d) it is possible to use CN~ in the System to distinguish the
CuZn Superoxide dismutase activity from the Mn Superoxide
dismutase activity.
We noted, however that this method leads to erroneous super-
oxide dismutase determination in all biological samples con-
taining low amounts of catalase. We present here a modification
of the Heikkila & Cabbat method, which gives accurate results.
Methods
Reagents
6-Hydroxydopamine and pure bovine blood Superoxide dismu-
tase were products of Sigma. Catalase (65000 U/mg, free of
Superoxide dismutase activity in accordance with Halliwell (2))
was from Boehringer Mannheim. All other chemicals were
analytical grade and were obtained from our usual commercial
source.
Sample preparation
Human fibroblasts were cultivated in vitro from skin explants.
They were sonicated in 20 mmol/1 Tris/40 mmol/1 KC1 at pH
7.4 with Triton X 100 at a final concentration of 10 g/l and the
Suspension was centrifuged at 110000# for 30 min. Protein
was determined with the Biorad Protein Assay using bovine
serum albumin s Standard.
Human red cells, from heparinized venous blood, were washed
twice in saline and haemolysed with 4 volumes of distilled
water. To eliminate haemoglobin 0.4 ml of ethanol/chloroform
(6.25/3.25, by vol.) was added to each ml of haemolysate and,
after shaking, the Suspension was centrifuged at 27000g for
30 min. Haemoglobin was measured with the Drabkin method
(B ehringer Cyanmethaemoglobin Standard Test).
Superoxide dismutase assay
We used the Heikkila & Cabbat method (1). Final concentra-
tions in the reaction medium were 50 mmol/1 sodium phosphate
buffer, pH 7.4, 100 μηιοΐ/ΐ EDTA, and 160 μηιοΐ/ΐ 6-hydroxy-
dopamine, prepared in l mmol/1 KC1, pH 2.0, to avoid oxida-
tion. We added 4.67 mg/1 of catalase to the experimental sample,
and the assay was run at 37 °C.
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Stat is t ical analysis
Sfudenfs t-test was used to compare the observed average
percentage increment, either positive or negative, with an arbi-
trarily fixed ± 10%, which was chosen s the maximal incre-
ment over the basal value that could be due to experimental
error.
Results
The effect of catalase on the rate of production of /?-benzoqui-
none was tested during the linear phase of the autoxidation
reaction; catalase decreased by 32% the rate of p-benzoquinone
production of a 0.16 mmol/1 6-hydroxydopamine solution. In
agreement with the results of Sullivan et al. (3), this effect is
dose-dependent until a Saturation point is reached. In our
System Saturation was reached at a catalase concentration of
4.67 mg/1.
Table l gives our results for the Superoxide dismutase activity
of different biological samples determined in the presence (ex-
perimental sample) and absence (control sample) of added
catalase. The determined activities of pure bovine Superoxide
dismutase and the Superoxide dismutase of in vitro fibroblasts
are clearly increased by the presence of catalase, mean activities
increasing by 25% and 45% respectively. No increase is seen,
however, in the red cell lysate deprived of haemoglobin. In
order to understand this difference we measured the endoge-
nous catalase (4) in both extracts: the in vitro fibroblasts have
an average (n = 5) value of 10.95 ± 1.44 and red cell lysates
an average (n = 10) value of 111.0 ± 12.76 kU/g protein which
is ten times greater. It is therefore concluded that the endoge-
nous catalase of the haemolysate is sufficient to saturate the
6-hydroxydopamine present.
Tab. l. Effect of catalase in the 6-hydroxydopamine assay for
Superoxide dismutase activity. Mean of kU/g protein
± S. E.; ns = not significant; *0.05 > p > 0.02; **p
< 0.01
Sample Superoxide dismutase activity Increase
basal + catalase
4.67 mg/1
Bovine Superoxide 2584 ± 114 3237 ±122 + 25*
dismutase (Sigma)
n = 10
In vitro fibroblasts 34.52 ± 9.50 49.7 ±15.9 -h 45*
n = 5
Red cell lysates 2.76 ± 0.25 3.51 ± 0.31 + 27**
n = 10
Red cell lysates 3.87 ± 0.26 3.68 ± 0.19 ns
without haemo-
globin n = 10
We also tested the activity of bovine Superoxide dismutase
(n = 10) in the presence of 100 μηιοΐ/ΐ azide and obtained an
average value of 2003 ± 68 kU/g protein which is 22% lower
than the average value obtained in the absence of azide (2538
± 114). The difference is statistically significant with p < 0.05.
To study the interference of haemoglobin in the assay System
we finally measured Superoxide dismutase activity in crude
haemolysates and in haemolysates tueated with Chloroform/
ethanol, which precipitates haemoglobin without affecting eata-
lase activity. In the haemolysates without haemoglobin the
Superoxide dismutase activity appears significantly higher
(27%, p < 0.01) than in the cfude haemolysate.
Discussion
According to Sullivan et al. (3), autoxidation of 6-hydroxydop·^
amine produces H2O2 s well s O "2, and the peroxide would
contribute to the production of coloured/^benzoquinone. Con-
sequently, the presence of catalase can be expected tp increase
the inhibitory effect of Superoxide dismutase in the assay.
Nearly all biological samples cpntain endogenous catalase, but
in different amounts, and in some cases the Saturation point
of the 6rhydroxydopamine present in the assay is not reached.
In this c se the determination of Superoxide dismutase is inaccu-
rate. The data presented in the table clearly illustrates this
point.
Sullivan et al. (3) have suggested the use of azide, an inhibitor of
catalase, to standardize the conditions of Superoxide dismutase
activity assay from tissue extracts. However the amount of
azide needed to inhibit the whole catalase activity of any extract
is of the order of 100 μηοκ>1/1. According to our data (see results)
this amount also inhibits the Superoxide dismutase enzyme,
thus leading to an incorrect determination.
We have also noticed that the measurement of Superoxide
dismutase activity in crude haemolysates without the addition
of catalase is not reliable, even though the activity of endoge-
nous catalase may be high. A reasonable explanation of these
results is the large production of H2O2 by the haemoglobin
(5—7). We therefore consider it preferable to eliminate the
haemoglobin. In our experience the epinephrine method (8) for
the determination of erythrocyte Superoxide dismutase activity
is more precise and less infl enced by ihterfering factors. In
conclusion, when 6-hydroxydopamine is used for the assay, it
is important to standardize the procedure by adding sufficient
catalase to saturate the 6-hydroxydoparnine, particularly if
different tissues are to be compared with unknown endogenous
catalase activities.
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